EFFECT OF ONCE-WEEKLY RIFAPENTINE AND ISONIAZID ON THE PHARMACOKINETICS OF TWICE-DAILY DORAVIRINE IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Lam, E. [1 ]
Zheng, R. [1 ]
Schaefer, J. [2 ]
Kraft, W. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-009
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [11] Once-weekly exenatide reduces HbA1c more than the twice-daily formulation
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2009, 5 (2): : 67 - 67
  • [12] Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Weiner, Marc
    Savic, Radojka M.
    Mac Kenzie, Awilliam R.
    Wing, Diane
    Peloquin, Charles A.
    Engle, Melissa
    Bliven, Erin
    Prihoda, Thomas J.
    Gelfond, Jonathan A. L.
    Scott, Nigel A.
    Abdel-Rahman, Susan M.
    Kearns, Gregory L.
    Burman, William J.
    Sterling, Timothy R.
    Villarino, M. Elsa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (02) : 132 - 145
  • [13] Comparison of pantoprazole 20 mg twice daily with 40 mg once daily on intragastric pH in healthy volunteers.
    Mönnikes, H
    Weber, S
    Tebbe, J
    Lühmann, R
    Fischer, R
    Arnold, R
    Koop, H
    GASTROENTEROLOGY, 1998, 114 (04) : A232 - A232
  • [14] Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)
    Raskin, Philip
    Mohan, Alok
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2269 - 2271
  • [15] Gastrointestinal tolerability with twice-daily or once-weekly exenatide formulations was not predicted by concentration with long-term treatment
    Cirincione, B.
    Edwards, J.
    Aisporna, M.
    MacConell, L.
    DIABETOLOGIA, 2013, 56 : S363 - S363
  • [16] PHARMACOKINETICS OF NETILMICIN ADMINISTERED ONCE OR TWICE-DAILY BY SUBCUTANEOUS INJECTION
    COURCOL, RJ
    POL, A
    DUFAY, C
    LAFITTE, C
    MARTIN, GR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (05) : 646 - 647
  • [17] Twice-Daily Dolutegravir-Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention
    Podany, Anthony T.
    Cramer, Yoninah
    Imperial, Marjorie
    Rosenkranz, Susan L.
    Avihingsanon, Anchalee
    Arduino, Roberto
    Samaneka, Wadzanai
    Gelmanova, Irina
    Savic, Rada
    Swindells, Susan
    Dawson, Rodney
    Luetkemeyer, Anne F.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 983 - 989
  • [18] Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes
    Watanabe, Yuusuke
    Saisho, Yoshifumi
    Inaishi, Jun
    Kou, Kinsei
    Yamauchi, Akira
    Kanazawa, Yasuhiko
    Okubo, Yoshiaki
    Tokui, Mikiya
    Imai, Takatoshi
    Murakami, Rie
    Tsuchiya, Tami
    Sasaki, Hironobu
    Masaoka, Tatsuhiro
    Irie, Junichiro
    Meguro, Shu
    Itoh, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (02) : 382 - 388
  • [19] Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus
    Ji, Linong
    Onishi, Yukiko
    Ahn, Chul Woo
    Agarwal, Pankaj
    Chou, Chien-Wen
    Haber, Harry
    Guerrettaz, Kelly
    Boardman, Marilyn K.
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (01) : 53 - 61
  • [20] Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes
    Saisho, Y.
    Watanabe, Y.
    Inaishi, J.
    Kou, K.
    Yamauchi, A.
    Kanazawa, Y.
    Okubo, Y.
    Tokui, M.
    Imai, T.
    Masaoka, T.
    Irie, J.
    Meguro, S.
    Itoh, H.
    DIABETOLOGIA, 2019, 62 : S374 - S374
12345